MX350709B - Composiciones y procedimientos antipaludismo. - Google Patents

Composiciones y procedimientos antipaludismo.

Info

Publication number
MX350709B
MX350709B MX2014011713A MX2014011713A MX350709B MX 350709 B MX350709 B MX 350709B MX 2014011713 A MX2014011713 A MX 2014011713A MX 2014011713 A MX2014011713 A MX 2014011713A MX 350709 B MX350709 B MX 350709B
Authority
MX
Mexico
Prior art keywords
vaccine against
against malaria
multilayer films
microparticle vaccine
host
Prior art date
Application number
MX2014011713A
Other languages
English (en)
Spanish (es)
Other versions
MX2014011713A (es
Inventor
Thomas J Powell
Original Assignee
Artificial Cell Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artificial Cell Tech Inc filed Critical Artificial Cell Tech Inc
Publication of MX2014011713A publication Critical patent/MX2014011713A/es
Publication of MX350709B publication Critical patent/MX350709B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2014011713A 2012-03-30 2013-03-20 Composiciones y procedimientos antipaludismo. MX350709B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261617998P 2012-03-30 2012-03-30
PCT/US2013/033070 WO2013148426A1 (en) 2012-03-30 2013-03-20 Microparticle vaccine against malaria

Publications (2)

Publication Number Publication Date
MX2014011713A MX2014011713A (es) 2015-02-04
MX350709B true MX350709B (es) 2017-09-14

Family

ID=48050943

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014011713A MX350709B (es) 2012-03-30 2013-03-20 Composiciones y procedimientos antipaludismo.

Country Status (12)

Country Link
US (1) US9433671B2 (https=)
EP (1) EP2830653B1 (https=)
JP (1) JP6335876B2 (https=)
CN (1) CN104244971B (https=)
AU (1) AU2013240105B2 (https=)
BR (1) BR112014024374B1 (https=)
CA (1) CA2868450C (https=)
DK (1) DK2830653T3 (https=)
ES (1) ES2885806T3 (https=)
IL (1) IL234694B (https=)
MX (1) MX350709B (https=)
WO (1) WO2013148426A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012018628A1 (en) 2010-07-26 2012-02-09 Board Of Regents, The University Of Texas System Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
US9974850B2 (en) 2013-01-25 2018-05-22 Board Of Regents, The University Of Texas System Immunogenic compositions and uses thereof
US9968665B2 (en) 2015-09-16 2018-05-15 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
WO2017075053A1 (en) * 2015-10-26 2017-05-04 Cour Pharmaceuticals Development Company Inc. Immune-modifying particles for the treatment of malaria
AU2019355843A1 (en) * 2018-10-04 2021-03-04 Artificial Cell Technologies, Inc. Anti-malaria compositions and methods
WO2024063789A1 (en) * 2022-09-23 2024-03-28 BioNTech SE Compositions for delivery of malaria antigens and related methods
JP2025533527A (ja) * 2022-09-23 2025-10-07 ビオンテック・ソシエタス・エウロパエア Ｐｌａｓｍｏｄｉｕｍ ＣＳＰ抗原の送達のための組成物及び関連方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69426077T3 (de) 1993-05-25 2004-09-02 Wyeth Holdings Corp. Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
DE10001172A1 (de) 2000-01-13 2001-07-26 Max Planck Gesellschaft Templatieren von Feststoffpartikeln mit Polymermultischichten
EP1615665A4 (en) 2003-04-10 2010-10-06 3M Innovative Properties Co DISTRIBUTION OF THE IMMUNE RESPONSE MODIFYING LINKS
US7615530B2 (en) 2003-08-29 2009-11-10 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
US7348399B2 (en) 2003-08-29 2008-03-25 Louisiana Tech University Foundation, Inc. Nanofabricated polypeptide multilayer films, coatings, and microcapsules
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
US20080233143A1 (en) 2005-02-07 2008-09-25 Lipotek Pty Ltd. Adjuvanting Material
DE102005044400A1 (de) 2005-09-16 2007-03-22 Capsulution Nanoscience Ag Verfahren zur Verkapselung und kontrollierten Freisetzung von schwer wasserlöslichen (hydrophoben) flüssigen und festen Wirkstoffen
CN101365724A (zh) 2005-10-25 2009-02-11 路易斯安那科技大学研究基金会 包含多肽的多层膜、涂层和微粒
EP1988896A4 (en) 2006-02-22 2011-07-27 3M Innovative Properties Co CONJUGATES TO MODIFY IMMUNE REACTIONS
US20080149123A1 (en) 2006-12-22 2008-06-26 Mckay William D Particulate material dispensing hairbrush with combination bristles
US7723294B2 (en) 2007-04-02 2010-05-25 Artificial Cell Technologies, Inc. Polypeptide films and methods
EP2002847A1 (en) 2007-06-12 2008-12-17 Capsulution Nanoscience AG Drug-releasing polyelectrolyte coating, method for forming a drug-releasing polyelectrolyte coating, and implantable device
WO2009082440A2 (en) 2007-12-18 2009-07-02 Vaxinnate Corporation Compositions of toll-like receptor agonists and malaria antigens and methods of use
US7846824B2 (en) 2008-03-18 2010-12-07 Applied Materials, Inc. Methods for forming a titanium nitride layer
JP2012523379A (ja) * 2009-04-09 2012-10-04 ザ ユニバーシティー オブ メルボルン 免疫原性組成物およびその使用
CN106008716B (zh) 2010-07-07 2019-08-13 人工细胞科技公司 呼吸道合胞病毒抗原组合物和方法
US8883717B2 (en) 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods

Also Published As

Publication number Publication date
DK2830653T3 (da) 2021-09-13
CN104244971A (zh) 2014-12-24
IL234694B (en) 2021-09-30
US20130259945A1 (en) 2013-10-03
BR112014024374B1 (pt) 2022-10-18
CA2868450A1 (en) 2013-10-03
CN104244971B (zh) 2016-09-07
EP2830653A1 (en) 2015-02-04
HK1206972A1 (en) 2016-01-22
JP6335876B2 (ja) 2018-05-30
AU2013240105B2 (en) 2016-10-20
JP2015514087A (ja) 2015-05-18
CA2868450C (en) 2021-02-23
US9433671B2 (en) 2016-09-06
MX2014011713A (es) 2015-02-04
ES2885806T3 (es) 2021-12-15
EP2830653B1 (en) 2021-08-11
AU2013240105A1 (en) 2014-10-02
WO2013148426A1 (en) 2013-10-03
IL234694A0 (en) 2014-11-30
BR112014024374A2 (https=) 2017-06-20

Similar Documents

Publication Publication Date Title
MX2014011713A (es) Composiciones y procedimientos antipaludismo.
MX2015008847A (es) Composiciones inmunogenicas de virus de influenza y usos de las mismas.
EP3110401A4 (en) Lipid nanoparticle vaccine adjuvants and antigen delivery systems
MX2024010676A (es) Metodos para mejorar la eficacia de una vacuna mediante el uso de un antagonista il-4r.
MX340796B (es) Composiciones y procedimientos antigenicos del virus respiratorio sincitial.
IN2014KN03063A (https=)
WO2011103453A3 (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
ZA201805547B (en) Novel antigen for use in malaria vaccine
WO2012024621A3 (en) Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
ZA201503404B (en) Single dose recombinant bovine fsh after follicular synchronisation
MX2014011712A (es) Composiciones antigenas y procedimientos.
EP3210621A4 (en) Micellar polypeptide vaccine having pegylated phospholipids as carrier
DK3352783T3 (da) Vaccine omfattende immun-isolerede celler som producerer en immunmodulator
WO2015179270A3 (en) Combinatorial platform for the display of surface adjuvants and antigens
WO2013188673A3 (en) Reassortant btv and ahsv vaccines
PL3402802T3 (pl) Kompozycje i sposoby generowania odpowiedzi immunologicznej względem antygenu powiązanego z guzem nowotworowym
MX2018003103A (es) Composiciones y procedimientos contra la malaria.
MX2016012932A (es) Procedimientos novedosos para inducir una respuesta inmune.
EP3027205A4 (en) Vaccine formulations that induce a th2 immune response
EP2785370A4 (en) VACCINE AGAINST FALCIPARUM MALARIA
WO2015149016A3 (en) Breast and ovarian cancer vaccines
EP3434280A4 (en) RECOMBINANT HANSENULA-BASED HIGH-DOSE HEPATITIS B VACCINE
HK1245095A1 (zh) 依维莫司(everolimus)与达托里昔布(dactolisib)的医药组合
WO2015070207A3 (en) Ama-1 epitopes, antibodies, compositions, and methods of making and using the same
HK1224187A1 (zh) 针对药物成瘾的疫苗组合物

Legal Events

Date Code Title Description
FG Grant or registration